Brokerages Set Verve Therapeutics, Inc. (NASDAQ:VERV) PT at $30.00
Verve Therapeutics, Inc. (NASDAQ:VERV – Get Free Report) has received an average recommendation of “Hold” from the seven ratings firms that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and four have assigned a buy recommendation to the […]
More Stories
SingularityNET 24 Hour Volume Hits $60,508.45 (AGIX)
SingularityNET (AGIX) traded down 3.1% against the dollar during the 24-hour period ending at 8:00 AM Eastern on December 28th....
ECOMI (OMI) Self Reported Market Capitalization Tops $105.35 Million
ECOMI (OMI) traded 6% lower against the U.S. dollar during the twenty-four hour period ending at 8:00 AM E.T. on...
Short Interest in AOT Growth & Innovation ETF (NASDAQ:AOTG) Rises By 300.0%
AOT Growth & Innovation ETF (NASDAQ:AOTG – Get Free Report) saw a significant increase in short interest during the month...
Sable Resources (CVE:SAE) Stock Price Down 16.7% – What’s Next?
Sable Resources Ltd. (CVE:SAE – Get Free Report)’s stock price was down 16.7% on Saturday . The stock traded as...
Short Interest in Allot Communications Ltd (NASDAQ:ALLT) Grows By 30.1%
Allot Communications Ltd (NASDAQ:ALLT – Get Free Report) was the target of a significant growth in short interest during the...
American Lithium Corp. (NASDAQ:AMLI) Sees Large Growth in Short Interest
American Lithium Corp. (NASDAQ:AMLI – Get Free Report) saw a significant growth in short interest in the month of December....